Stay updated on Secukinumab in Psoriatic Arthritis: Clinical Trial
Sign up to get notified when there's something new on the Secukinumab in Psoriatic Arthritis: Clinical Trial page.

Latest updates to the Secukinumab in Psoriatic Arthritis: Clinical Trial page
- Check6 days agoChange DetectedA minor versioning update was made: Revision: v3.3.4 added and Revision: v3.3.3 removed; this appears in site metadata and does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe Study Locations section was updated to include a broad set of site regions across the US (Arizona, California, Colorado, Florida, Illinois, Louisiana, Michigan, Missouri, Nebraska, New York, Oklahoma, Pennsylvania, South Carolina, Texas, Vermont, Washington), Australia (New South Wales, Queensland, Tasmania, Victoria), Canada (British Columbia, Manitoba, Quebec), the Czech Republic, and London; the HHS Vulnerability Disclosure link and several prior Location headings were removed.SummaryDifference2%

- Check49 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. This UI/backend update does not alter study content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe Publications section description was updated to reflect that entries are automatically filled from PubMed and may not pertain to the study; version updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedSite-wide government funding status notice was removed from the page. This change does not affect the study details, eligibility criteria, or other core content.SummaryDifference0.2%

- Check78 days agoChange DetectedNo substantive changes were detected in the Study Details page between the two screenshots; core content such as the title, conditions, interventions, outcomes, eligibility criteria, and locations remains unchanged, with only minor formatting differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Secukinumab in Psoriatic Arthritis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secukinumab in Psoriatic Arthritis: Clinical Trial page.